OraSure Technologies, Inc.
NASDAQ:OSURMedical - Instruments & Supplies
-$0.16 today
- Market cap
- $247.88M
- Beta
- 1.01
- P/E (TTM)
- -4.0
- EPS (TTM)
- -$1.08
Volume 0.49M
Average 0.61M
OSUR Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
OraSure Technologies, Inc.NASDAQ: OSUR
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue declines year over year
Q1 FY2026 revenue of $27.93M fell 6.7% year over year, ahead of the -30.1% change in trailing-twelve-month revenue. Sequentially, it rose 4.3% from the prior quarter. Over 3 fiscal years it compounded at -33.3% a year.
Context
- Revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 1 analysts of $120.36M (+4.6%) for the fiscal year ending Dec 2026, a step up from the -38.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $27.93M+4.3% QoQ
- Last fiscal yearDec 2025
- $115.02M-38.1% YoY
- LTMMar 2026
- $113.02M-30.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -6.7% | -6.9% | -0.2 pp |
| 1 year | -38.1% | +4.6% | +42.7 pp |
| 3-year CAGR | -33.3% | +7.3% | +40.6 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 115.02M USD
- Year-over-year change
- -38.1%
- 4-year CAGR
- -16.2%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 115.02M | -38.1% |
| FY2024 | 2024-12-31 | 185.83M | -54.2% |
| FY2023 | 2023-12-31 | 405.47M | +4.6% |
| FY2022 | 2022-12-31 | 387.48M | +65.8% |
| FY2021 | 2021-12-31 | 233.67M | — |
Revenue vs competitors
How OSUR compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of -30.1% is the 6th highest of 7, against a peer median of +52.1%.
- Over three fiscal years its annual growth of -33.3% compares with a peer median of +33.3%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $151.64M USD | +69.5% | +31.8% | |
| LTM Mar 2026 | $113.75M USD | +174.0% | +91.5% | |
| LTM Mar 2026 | $113.02M USD | -30.1% | -33.3% | |
| LTM Mar 2026 | $37.53M USD | -4.4% | -9.7% | |
| LTM Mar 2026 | $18.87M USD | +34.8% | +34.8% | |
| LTM Mar 2026 | €16.32M EUR | +273.9% | +48.1% | |
| LTM Mar 2026 | $618K USD | -58.0% | -50.1% | |
| LTM Mar 2026 | $0 USD | — | — | |
| LTM Mar 2026 | $0 USD | — | — | |
| LTM Mar 2026 | $0 USD | — | — | |
| Peer median (excluding OSUR) | — | +52.1% | +33.3% | |
Competitors are the stored peer set for OSUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 233.67M | 387.48M | 405.47M | 185.83M | 115.02M |
| Cost of Revenue | 116.07M | 239.04M | 226.05M | 109.6M | 66.82M |
| Gross Profit | 117.6M | 148.44M | 179.42M | 76.23M | 48.2M |
| Gross Margin | 50.3% | 38.3% | 44.2% | 41.0% | 41.9% |
| Research & Development | 34.17M | 36.24M | 33.16M | 24.42M | 42.53M |
| Selling, General & Admin | 95.08M | 117.44M | 92.18M | 72.41M | 73.79M |
| Operating Expenses | 129.25M | 153.68M | 125.34M | 96.83M | 116.32M |
| Depreciation & Amortization | 11.66M | 14M | 19.9M | 10.87M | 9.97M |
| EBITDA | 2.37M | (1.68M) | 76.16M | (6.83M) | (56.96M) |
| EBITDA Margin | 1.0% | -0.4% | 18.8% | -3.7% | -49.5% |
| Operating Income | (11.65M) | (5.24M) | 54.08M | (20.6M) | (68.12M) |
| Operating Margin | -5.0% | -1.4% | 13.3% | -11.1% | -59.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 2.36M | (10.43M) | 2.18M | 2.9M | 1.19M |
| Income Before Tax | (9.29M) | (15.68M) | 56.26M | (17.7M) | (66.93M) |
| Pre-Tax Margin | -4.0% | -4.0% | 13.9% | -9.5% | -58.2% |
| Income Tax Expense | 13.71M | 1.46M | 2.6M | 1.8M | 1.8M |
| Net Income | (23M) | (17.13M) | 53.66M | (19.5M) | (68.73M) |
| Net Margin | -9.8% | -4.4% | 13.2% | -10.5% | -59.8% |
| EPS (Basic) | (0.32) | (0.25) | 0.73 | (0.26) | (0.94) |
| EPS (Diluted) | (0.32) | (0.25) | 0.72 | (0.26) | (0.94) |
| Weighted Avg Shares | 71.98M | 72.51M | 73.35M | 74.43M | 73.49M |
| Weighted Avg Shares (Diluted) | 71.98M | 72.51M | 74.39M | 74.43M | 73.49M |
OraSure Technologies, Inc.
NASDAQ:OSUR
Intrinsic Alpha fair value
Locked
Current Price
$3.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.